Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.366
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antibiotic Prophylaxis With Meropenem After Allogeneic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2003English

Varicella-Zoster Reactivation After Allogeneic Stem Cell Transplantation Without Routine Prophylaxis—The Incidence Remains High

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

OncoTargets and Therapy
OncologyPharmacology
2015English

Pneumocystis Jirovecii Infection

Thorax
PulmonaryRespiratory Medicine
2004English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Incidence and Risk Factors for Nontuberculous Mycobacterial Infection After Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Safety and Efficacy of Prophylaxis for Pneumocystis Jirovecii Pneumonia Involving Trimethoprim-Sulfamethoxazole Dose Reduction in Kidney Transplantation

BMC Infectious Diseases
Infectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy